Watson, Endo Settle Generic Lidoderm Patent Suit
Watson Pharmaceuticals Inc. and Endo Pharmaceuticals Inc. have settled all of their outstanding patent litigation related to Watson's generic version of the brand-name lidocaine patch Lidoderm, the drugmakers said Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article